Drugs / t-PA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07119021 Background | Aug 2024 → Apr 2027 expected | ischemic stroke | Ruijun Ji | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | t-PA | “The patient underwent intravenous t-PA thrombolysis and sublingual administration of edaravone tablets in the prehospital ambulance.” NCT07119021 ↗ |
| Route | Intravenous | “The patient underwent intravenous t-PA thrombolysis” NCT07119021 ↗ |